Par Drugs and Chemicals Limited — Others, 23-10-2024: Copy of Newspaper Publication

Par Drugs and Chemicals Limited announced standalone unaudited financial results for the half-year and quarter ending September 30, 2024. Total income from operations was ₹3,567.29 lakhs, with a net profit of ₹1,112.89 lakhs after tax. The company reported an earnings per share of ₹6.99 for the period. This marks an improvement compared to the same quarter last year, reflecting strong operational performance. Additional details are available on their website.